383 related articles for article (PubMed ID: 15155136)
1. Emerging treatments in acute myeloid leukaemia.
Kell J
Expert Opin Emerg Drugs; 2004 May; 9(1):55-71. PubMed ID: 15155136
[TBL] [Abstract][Full Text] [Related]
2. Current and emerging therapies for acute myeloid leukemia.
Robak T; Wierzbowska A
Clin Ther; 2009; 31 Pt 2():2349-70. PubMed ID: 20110045
[TBL] [Abstract][Full Text] [Related]
3. Farnesyltransferase inhibitor therapy in acute myelogenous leukemia.
Gotlib J
Curr Hematol Rep; 2005 Jan; 4(1):77-84. PubMed ID: 15610664
[TBL] [Abstract][Full Text] [Related]
4. Therapy of acute myeloid leukemia: towards a patient-oriented, risk-adapted approach.
Mandelli F; Petti MC; Lo Coco F
Haematologica; 1998 Nov; 83(11):1015-23. PubMed ID: 9864924
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic targets in hematological malignancies: combination therapies with HDACis and demethylating agents.
Bishton M; Kenealy M; Johnstone R; Rasheed W; Prince HM
Expert Rev Anticancer Ther; 2007 Oct; 7(10):1439-49. PubMed ID: 17944568
[TBL] [Abstract][Full Text] [Related]
6. Repetitive cycles of high-dose cytarabine are effective for childhood acute myeloid leukemia: long-term outcome of the children with AML treated on two consecutive trials of Tokyo Children's Cancer Study Group.
Tomizawa D; Tabuchi K; Kinoshita A; Hanada R; Kigasawa H; Tsukimoto I; Tsuchida M;
Pediatr Blood Cancer; 2007 Aug; 49(2):127-32. PubMed ID: 16807916
[TBL] [Abstract][Full Text] [Related]
7. Current therapeutic strategies for acute myeloid leukaemia.
Kolitz JE
Br J Haematol; 2006 Sep; 134(6):555-72. PubMed ID: 16848792
[TBL] [Abstract][Full Text] [Related]
8. New agents in the treatment of acute myeloid leukemia: a snapshot of signal transduction modulation.
Bao T; Smith BD; Karp JE
Clin Adv Hematol Oncol; 2005 Apr; 3(4):287-96, 302. PubMed ID: 16167001
[TBL] [Abstract][Full Text] [Related]
9. Conventional chemotherapy or hypomethylating agents for older patients with acute myeloid leukaemia?
Ferrara F
Hematol Oncol; 2014 Mar; 32(1):1-9. PubMed ID: 23512815
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic efficacy of prenylation inhibitors in the treatment of myeloid leukemia.
Morgan MA; Ganser A; Reuter CW
Leukemia; 2003 Aug; 17(8):1482-98. PubMed ID: 12886235
[TBL] [Abstract][Full Text] [Related]
11. Novel agents in acute myeloid leukemia.
Aribi A; Ravandi F; Giles F
Cancer J; 2006; 12(2):77-91. PubMed ID: 16630396
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic mechanisms in AML - a target for therapy.
Oki Y; Issa JP
Cancer Treat Res; 2010; 145():19-40. PubMed ID: 20306243
[TBL] [Abstract][Full Text] [Related]
13. New agents for the treatment of acute myeloid leukemia.
Tallman MS
Best Pract Res Clin Haematol; 2006; 19(2):311-20. PubMed ID: 16516128
[TBL] [Abstract][Full Text] [Related]
14. Increasing dose intensity of anthracycline antibiotics improves outcome in patients with acute myelogenous leukemia.
Novitzky N; Thomas V; Abrahams L; du Toit C; McDonald A
Am J Hematol; 2004 Aug; 76(4):319-29. PubMed ID: 15282663
[TBL] [Abstract][Full Text] [Related]
15. Molecular characteristics therapy in AML.
Radich GP
Clin Adv Hematol Oncol; 2009 Jun; 7(6):11-4. PubMed ID: 19645131
[No Abstract] [Full Text] [Related]
16. FLT3 Inhibitors in the Treatment of AML.
Gilliland DG
Clin Adv Hematol Oncol; 2004 Nov; 2(11):708-10. PubMed ID: 16163256
[No Abstract] [Full Text] [Related]
17. Treatment of acute myeloid leukemia in older patients.
Roboz GJ
Expert Rev Anticancer Ther; 2007 Mar; 7(3):285-95. PubMed ID: 17338649
[TBL] [Abstract][Full Text] [Related]
18. Emerging drugs for head and neck cancer.
Rhee JC; Khuri FR; Shin DM
Expert Opin Emerg Drugs; 2004 May; 9(1):91-104. PubMed ID: 15155138
[TBL] [Abstract][Full Text] [Related]
19. Targeting epigenetic changes in acute myeloid leukemia.
Blum W; Marcucci G
Clin Adv Hematol Oncol; 2005 Nov; 3(11):855-65, 882. PubMed ID: 16491631
[TBL] [Abstract][Full Text] [Related]
20. Farnesyltransferase inhibitors as anticancer agents: critical crossroads.
Doll RJ; Kirschmeier P; Bishop WR
Curr Opin Drug Discov Devel; 2004 Jul; 7(4):478-86. PubMed ID: 15338957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]